Nucleic Acid Origami Delivers a Promising Genetic Therapy
A report published this week in Nature Nanotechnology describes a new method for delivering a genetic treatment called a short interfering RNA, or siRNA, which can turn off, or silence, a gene.
The sequence of an siRNA determines which gene it regulates. In theory, siRNAs could be a powerful therapeutic tool, silencing just about any human gene that has gone haywire in cancer or other disease. However, delivering the siRNAs to the right place in the body continues to be a challenge.
A team of researchers at the Massachusetts Institute of Technology, Harvard Medical School and Alnylam Pharmaceuticals built a three dimensional tetrahedron from six short pieces of DNA. They then glued RNA molecules to each edge and added small molecules to help target the complex to tumor cells. When injected into a mouse that had been implanted with human tumors, the nanoparticles accumulated at the tumor site and reduced the function of a gene that made the implanted tumors glow.
A comment on the work published in Nature Nanotechnology described the new method for delivering siRNAs to tumor cells a “metaphorical foot in the slowly closing door on siRNA therapeutics.”
Keep Reading
Most Popular
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
How to fix the internet
If we want online discourse to improve, we need to move beyond the big platforms.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.